Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-471P** encodes a pseudogene version of the small nuclear RNA U6 (snRNA U6), which is a highly conserved non-coding RNA essential for the catalytic core of the spliceosome. The U6 snRNA is involved in pre-mRNA splicing in the nucleus, interacting with other snRNAs and forming critical structures for intron excision[1][3]. However, RNU6-471P is annotated as a pseudogene, meaning it does not encode a functional U6 snRNA due to mutations or sequence features rendering it nonfunctional. While functional U6 snRNA is required for spliceosome activity, U6 pseudogenes like RNU6-471P are typically considered nonfunctional and do not produce active RNA or protein[5]. Some pseudogenes have been implicated in gene regulation through RNA-mediated mechanisms (such as acting as competitive endogenous RNAs or antisense transcripts), but there is currently no direct evidence that RNU6-471P has such a role[4][5]. It is not considered a therapeutically relevant target. **Summary of issues:** - RNU6-471P is a pseudogene, not a protein, receptor, enzyme, or other classical drug target class. - No direct biological or disease role has been demonstrated. - No known drug interactions, mechanism of action, biomarker, or safety concern associated. **References** - [1], [3]: Background on U6 snRNA function - [4]: General pseudogene regulatory roles and disease relevance - [5]: RNU6-471P gene annotation and identifiers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 471, pseudogene (RNU6-471P).